Hazel M. Aker, SVP, GC & Secretary at CADENCE PHARMACEUTICALS INC (CADX), sold 6,508 shares at $7.34 ($48K) on 2013-07-15, disclosed to the SEC on 2013-07-17.
Scheduled sale ($48k) by SVP, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CADX | SELL | 2013-11-18 | $385K | — | Filing → |
| CADX | SELL | 2013-07-23 | $51K | — | Filing → |
| CADX | SELL | 2011-11-22 | $42K | — | Filing → |